FDA considers psychedelic MDMA therapy for post-traumatic stress disorderDescription: A panel of advisors to the FDA on Tuesday will weigh whether the agency should approve the use of MDMA, also known as ecstasy, to treat post-traumatic stress disorder. CNN’s Chief Medical Correspondent Sanjay Gupta reports.
Must Read
Voting Begins For The Seattle Medium’s Best Of The Best Northwest...
The Seattle Medium has announced the nominees for its inaugural Best of the Best Northwest Readers' Choice Awards, with community voting scheduled from June 1 to June 19, 2026. This initiative seeks to recognize outstanding businesses, nonprofits, community leaders, educators, athletes, advocates, and cultural institutions throughout the Pacific Northwest.
